Legalising lower dosage cannabis products could 'ignite industry'

Legalising lower dosage cannabis products could 'ignite industry'
Mitch Cuevas, pharmaceutical director at Katikati based medicinal cannabis firm Eqalis, said NZ is 'missing out' on an obvious export opportunity. (Image: Eqalis)
Brent Melville
Easing restrictions on low-level cannabidiol (CBD) for over-the-counter sales could boost cannabis earnings fourfold, creating a $2 billion sector within the next eight years, a new report says.Dr Nick Marsh, an analyst and consultant with Next Corp, said regulatory reform allowing expanded use of low potency CBD for nutraceuticals and food products could ignite the industry’s earning power.In New Zealand, any strength CBD is scheduled as a restricted medicine under the Medicines Act and therefore must be prescribed by a medical professio...

More Health

Southern Cross pays record 3.8 million claims
Law & Regulation

Southern Cross pays record 3.8 million claims

Rising demand and more frequent claims push up costs, directly impacting premiums.

John Anthony 30 Sep 2025
Fisher & Paykel Healthcare shares dip on new tariff fears
Markets

Fisher & Paykel Healthcare shares dip on new tariff fears

US Department of Commerce launched a “Section 232” on medical products.

Gregor Thompson 25 Sep 2025
NZer creates world's first waste-free drink
Retail

NZer creates world's first waste-free drink

They are tiny, concentrated balls of flavours and vitamins which dissolve in liquid.

Oceania forecasts sales lift as it targets debt
Property

Oceania forecasts sales lift as it targets debt

It said sales applications had lifted 23% between July and August.

Gregor Thompson 16 Sep 2025